Dayer P - Search Results

1

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors.

Transon C, Leemann T, Dayer P. Transon C, et al. Among authors: dayer p. Eur J Clin Pharmacol. 1996;50(3):209-15. doi: 10.1007/s002280050094. Eur J Clin Pharmacol. 1996. PMID: 8737761

2

New approaches to the pharmacotherapy of neuropathic pain.

Besson M, Piguet V, Dayer P, Desmeules J. Besson M, et al. Among authors: dayer p. Expert Rev Clin Pharmacol. 2008 Sep;1(5):683-93. doi: 10.1586/17512433.1.5.683. Expert Rev Clin Pharmacol. 2008. PMID: 24422738

3

Incorporation of flurbiprofen in a 4-drug cytochrome p450 phenotyping cocktail.

Bosilkovska M, Clément M, Dayer P, Desmeules J, Daali Y. Bosilkovska M, et al. Among authors: dayer p. Basic Clin Pharmacol Toxicol. 2014 Nov;115(5):465-6. doi: 10.1111/bcpt.12231. Epub 2014 Apr 25. Basic Clin Pharmacol Toxicol. 2014. PMID: 24674230 Free article. Clinical Trial. No abstract available.

4

Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study.

Besson M, Daali Y, Di Lio A, Dayer P, Zeilhofer HU, Desmeules J. Besson M, et al. Among authors: dayer p. Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):192-7. doi: 10.1111/bcpt.12017. Epub 2012 Nov 14. Basic Clin Pharmacol Toxicol. 2013. PMID: 23006671 Free article.

5

Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients.

Daali Y, Ancrenaz V, Bosilkovska M, Dayer P, Desmeules J. Daali Y, et al. Among authors: dayer p. Metabolism. 2011 Nov;60(11):1584-9. doi: 10.1016/j.metabol.2011.03.015. Epub 2011 May 6. Metabolism. 2011. PMID: 21550074

6

P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone.

Kanaan M, Daali Y, Dayer P, Desmeules J. Kanaan M, et al. Among authors: dayer p. Fundam Clin Pharmacol. 2009 Oct;23(5):543-8. doi: 10.1111/j.1472-8206.2009.00724.x. Epub 2009 Jul 28. Fundam Clin Pharmacol. 2009. PMID: 19656202

7

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.

Vuilleumier N, Rossier MF, Chiappe A, Degoumois F, Dayer P, Mermillod B, Nicod L, Desmeules J, Hochstrasser D. Vuilleumier N, et al. Among authors: dayer p. Eur J Clin Pharmacol. 2006 Jun;62(6):423-9. doi: 10.1007/s00228-006-0111-5. Epub 2006 Apr 27. Eur J Clin Pharmacol. 2006. PMID: 16770646 Free article.

8

Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain.

Ehret GB, Daali Y, Chabert J, Rebsamen M, Wolff A, Forster A, Moursli F, Fritschy D, Rossier MF, Piguet V, Dayer P, Gex-Fabry M, Desmeules JA. Ehret GB, et al. Among authors: dayer p. Pain Physician. 2013 Jan;16(1):45-56. Pain Physician. 2013. PMID: 23340533 Free article. Clinical Trial.

9

A simplified analytical method for a phenotyping cocktail of major CYP450 biotransformation routes.

Jerdi MC, Daali Y, Oestreicher MK, Cherkaoui S, Dayer P. Jerdi MC, et al. Among authors: dayer p. J Pharm Biomed Anal. 2004 Sep 3;35(5):1203-12. doi: 10.1016/j.jpba.2004.03.021. J Pharm Biomed Anal. 2004. PMID: 15336365

10

Codeine intoxication associated with ultrarapid CYP2D6 metabolism.

Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J. Gasche Y, et al. Among authors: dayer p. N Engl J Med. 2004 Dec 30;351(27):2827-31. doi: 10.1056/NEJMoa041888. N Engl J Med. 2004. PMID: 15625333 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results